Μετάβαση στο περιεχόμενο

ΕτικέταOpdivo

Bristol-Myers Squibb’s Opdivo Gets New Approval for Lung Cancer Indication

The U.S. Food and Drug Administration (FDA) gave Bristol-Myers Squibb’s Opdivo (nivolumab) approval for metastatic small cell lung cancer (SCLC) for patients whose cancer has progressed after platinum-based chemotherapy and at least one other type of … Continue Reading Bristol-Myers Squibb’s Opdivo Gets New Approval for Lung Cancer Indication